Premenstrual Syndrome (PMS) and Mindfulness Stress Reduction Program (MSRP) (PMS and MSRP)
Premenstrual Syndrome
About this trial
This is an interventional prevention trial for Premenstrual Syndrome focused on measuring mindfulness, premenstrual syndrome
Eligibility Criteria
Inclusion Criteria:
- be between the ages of 18-30
- Having a score of 45 or more on the PMS scale
- Regular menstruation (between 21-35 days)
- Knowing Turkish (being literate)
- Read and approve the voluntary consent form
Exclusion Criteria:
- Having any gynecological disease (abnormal uterine bleeding, uterine fibroids, ovarian cysts, hormonal treatment, etc.),
- Having a chronic or physical illness (having serious hearing and vision problems, vestibular disorders that can cause balance loss)
- Having any problem that prevents communication (such as not knowing Turkish, having impairment in hearing, speaking and understanding abilities)
- Receiving a psychiatric treatment (Pharmacotherapy or psychotherapy)
- Do not use pharmacological or non-pharmacological applications to reduce the symptoms of premenstrual symptoms.
Sites / Locations
- NURDİLAN
- Kırklareli Üniversitesi
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
The Effect of mİNDFULNESS Stress Reduction Program on Premenstrual Symptoms
Control group
In order to prevent bias in the study groups, the Introductory Information Form and PMSS scale will be applied via online Google forms. Participants who meet the criteria will be randomly assigned to the mindfulness stress reduction group (Group 1) and control group (Group 2) in the number determined by power analysis and a simple random number generator program (www.random.org). These experimental and control groups will be recorded by the researchers as a list. Participants participating in the study will be informed about the mindfulness stress reduction application, but they will not be informed about what the mindfulness stress reduction application does (single-blind method). These participants will be asked to sign the consent form by expressing that they can withdraw from the study at any time.
not routinely do anything to reduce premenstrual symptoms